Home » Topics » Regulatory » Patents

Patents
RSS

Sunshine Lake Pharma synthesizes new GTPase KRAS inhibitors

July 11, 2022

XuanZhu Pharma identifies new AhR antagonists

July 11, 2022

Gritscience Biopharmaceuticals describes new casein kinase inhibitors

July 11, 2022

H. Lundbeck A/S discloses new NMDA glycine-site receptor modulators

July 11, 2022

Nanjing Shijiang Medicine Technology patents new compounds for cancer

July 11, 2022

BioWorld MedTech Patent Highlights: Week 26

From Current Patent Gazette

July 8, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

New ROCK-1/2 inhibitors identified at Chiesi Farmaceutici

July 8, 2022

Shanghai Institute of Materia Medica describes thyroid hormone receptor agonists

July 8, 2022

New pantetheinase inhibitors discovered at Shanghai Meiyue Biotech Development

July 8, 2022

Shanghai Jemincare Pharmaceuticals, Jiangxi Jemincare Group present SLC9A3 inhibitors

July 8, 2022

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...